Letter to the Editor

 

Authors

  • Paolo A. Ascierto Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Napoli, Italy

DOI:

https://doi.org/10.19156/cbn.2017.0040

Abstract

No abstract available